mitoxantrone has been researched along with Benign Paroxysmal Peritonitis in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kale, N | 1 |
| Icen, M | 1 |
| Agaoglu, J | 1 |
| Yazici, I | 1 |
| Tanik, O | 1 |
| Kümpfel, T | 1 |
| Hoffmann, LA | 1 |
| Pellkofer, H | 1 |
| Pöllmann, W | 1 |
| Feneberg, W | 1 |
| Hohlfeld, R | 1 |
| Lohse, P | 1 |
2 other studies available for mitoxantrone and Benign Paroxysmal Peritonitis
| Article | Year |
|---|---|
Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.
Topics: Activities of Daily Living; Autoimmune Diseases; Autoimmunity; Brain; Cluster Analysis; Connective T | 2008 |
Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arginine; Familial Mediterranean F | 2008 |